MyVisionTest News Archive

Displaying news items tagged with clinical trial (More tags »)
SELECT PAGE
First <<  1 2 3 4 5 6 7   >> Last

Central serous chorioretinopathy
Nov 12, 2008
A new study reports good success treating acute central serous chorioretinopathy with a novel safety-enhanced photodynamic therapy protocol. Central serous chorioretinopathy (CSCR) is characterized by the accumulation of subretinal fluid at the macula and is a common condition in young adults, especially in men with a so-called type A...

Full Article


CABERNET study logo
Oct 11, 2008
NeoVista, Inc. made public yesterday 18-month data from the company's Phase II feasibility study examining its novel epiretinal brachytherapy for treatment of the wet form of age-related macular degeneration (AMD) at the 41st Scientific Meeting of the Retina Society. The long-term data from the study, which was initiated to test the safety...

Full Article


VEGF intravitreal injection
Oct 11, 2008
VEGF Trap-Eye can achieve durable improvements in visual acuity and in biologic measurement parameters in the formation of new blood vessels in the treatment of age-related macular degeneration (AMD). This was shown in the final evaluation of a Phase 2 study presented at the annual meeting of the Retina Society in Scottsdale, Arizona. The...

Full Article


Rheo logo
May 22, 2008
In Austria, Rheopheresis for non-exudative age-related macular degeneration (AMD) has been proposed for inclusion into the benefit catalogue. Decisions on the inclusion of new medical interventions in reimbursement schemes or benefit catalogues are increasingly based on systematic reviews of clinical studies and their patient-relevant results....

Full Article


Visudyne
May 5, 2008
QLT Inc. today announced it has completed enrolling 160 patients in the Company's Phase II RADICAL trial to determine if combination therapy with Visudyne reduces retreatment rates compared with an anti-VEGF antibody while maintaining similar vision outcomes and an acceptable safety profile. "The completion of enrollment in the RADICAL trial...

Full Article


Lucentis
Apr 30, 2008
Early results from the READ-2 study presented Monday at the 2008 Annual Meeting of The Association for Research in Vision and Ophthalmology find that the drug Lucentis (ranibizumab) for the treatment of diabetic eye disease has performed better in clinical trials than the current standard treatment using laser surgery. The multi-center READ-2...

Full Article


CABERNET study logo
Apr 19, 2008
NeoVista, Inc. announced that the FDA has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States. The approved expansion of CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) trial, which seeks to evaluate the safety and efficacy of the...

Full Article


SELECT PAGE
First <<  1 2 3 4 5 6 7   >> Last
Most Popular
Less - past - More